Stueland Katherine bought WGS
July 29, 2025 · Form 4 insider transaction
Stueland Katherine bought 3,874 shares of GeneDx Holdings Corp. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,874
Price
$0.00
Total value
N/A
InsiderStueland Katherine
RoleOfficer, Director
CompanyGeneDx Holdings Corp. (WGS)
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateJuly 29, 2025
Filing dateJuly 31, 2025
Shares owned after5,594
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.